Veracyte (VCYT) Total Debt Growth (1y) (2014 - 2026)
Veracyte (VCYT) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 56.63% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -0.06% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 3.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -20.41% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -3.29% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 15.39% |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn | -95.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -95.07% |
| Mar 31, 2026 | -93.16% |
| Dec 31, 2025 | -92.16% |
| Sep 30, 2025 | 83.62% |
| Jun 30, 2025 | 82.57% |
| Mar 31, 2025 | 107.10% |
| Dec 31, 2024 | 539.10% |
| Sep 30, 2024 | 187.14% |
| Jun 30, 2024 | 118.76% |
| Mar 31, 2024 | 110.12% |
| Dec 31, 2023 | -63.40% |
| Sep 30, 2023 | -63.75% |
| Jun 30, 2023 | -52.90% |
| Mar 31, 2023 | -12.74% |
| Dec 31, 2022 | 170.69% |
| Sep 30, 2022 | 90.81% |
| Jun 30, 2022 | 66.15% |
| Mar 31, 2022 | -44.78% |
| Dec 31, 2021 | 231.11% |
| Sep 30, 2021 | 392.20% |